Literature DB >> 18389669

On-line autotransfusion waste calculator.

Jeffrey B Riley1, Keith A Samolyk.   

Abstract

Cell concentrating and washing techniques are widely accepted and believed to be beneficial to cardiac surgery patients. During cell processing, platelets, proteins, and clotting factors are wasted as the plasma is washed away by saline. Beneficial and costly plasma constituents are sacrificed for the sake of removing potentially harmful drugs, debris, and naturally activated cells and chemical mediators. An interactive Microsoft Excel spreadsheet was designed to input patient and autotransfusion system (ATS) reservoir blood values, processed centrifugal bowl data, and hospital allogeneic blood product concentration and cost information. The spreadsheet calculates the number of wasted platelets, grams of protein, and milligrams of fibrinogen. The calculator further estimates the number of units and cost of allogeneic blood products needed to replace the wasted blood components. The simulation allows for variable levels of platelet activation and protein removal during centrifugal cell processing. Specific case scenarios may be simulated with the calculator. If a known volume of residual extracorporeal circuit blood with a known hematocrit, platelet count, and protein concentration is diverted to the ATS reservoir to be processed and washed after bypass, the number of units of fresh frozen plasma, platelet packs, and albumin concentrate needed to replace the wasted proteins and platelets may be calculated. When typical end-bypass patient and blood bank product values are input, the cost to replace the wasted blood components in 1550 mL of residual circuit blood with allogeneic blood products is about US $2097. There are risks and costs associated with replacing the platelets, proteins, and clotting factors wasted during cell washing compared with other techniques such as whole blood ultrafiltration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18389669      PMCID: PMC4680660     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  11 in total

1.  Quality of red blood cells using autotransfusion devices: a comparative analysis.

Authors:  Cyril J Serrick; Mary Scholz; Arthur Melo; Onkar Singh; Dionne Noel
Journal:  J Extra Corpor Technol       Date:  2003-03

2.  Observations from a national multiple institution autotransfusion (ATS) quality indicator program.

Authors:  Timothy Dickinson; Jeffrey Riley; Ana Steg; Paul Zabetakis
Journal:  J Extra Corpor Technol       Date:  2004-06

Review 3.  Transfusion of blood products affects outcome in cardiac surgery.

Authors:  Bruce D Spiess
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2004-12

Review 4.  Blood conservation strategies in cardiac surgery.

Authors:  P Van der Linden; A Dierick
Journal:  Vox Sang       Date:  2007-02       Impact factor: 2.144

5.  Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.

Authors:  Conrad V Bishop; William E P Renwick; Chris Hogan; Michael Haeusler; Annabel Tuckfield; James Tatoulis
Journal:  Ann Thorac Surg       Date:  2006-03       Impact factor: 4.330

6.  A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag.

Authors:  Keith A Samolyk; Scott R Beckmann; Randall C Bissinger
Journal:  Perfusion       Date:  2005-10       Impact factor: 1.972

7.  Ultrafiltration of the waste plasma effluent from cardiopulmonary bypass circuit contents processed with a cell-washing device.

Authors:  A H Stammers; J F Morrow; C P Brady; J J Deptula; S M Huffman; A S Bonness; T A Galbraith; A Alonso
Journal:  J Extra Corpor Technol       Date:  1996-09

8.  A modified collection and rapid infusion system for shed whole blood autotransfusion during aortic aneurysm surgery.

Authors:  R J Dekkers; R J Rizzo; D J Fitzgerald; L H Cohn
Journal:  J Extra Corpor Technol       Date:  1995-12

9.  Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement.

Authors:  Manuel Muñoz; Daniel Ariza; María J Garcerán; Aurelio Gómez; Arturo Campos
Journal:  Arch Orthop Trauma Surg       Date:  2005-04-09       Impact factor: 3.067

Review 10.  The ethics of blood management.

Authors:  K Sazama
Journal:  Vox Sang       Date:  2007-02       Impact factor: 2.144

View more
  1 in total

1.  An in-vitro comparison between Hemobag and non-Hemobag ultrafiltration methods of salvaging circuit blood following cardiopulmonary bypass.

Authors:  Ed Delaney; David Rosinski; Harvey Ellis; Keith A Samolyk; Jeffrey B Riley
Journal:  J Extra Corpor Technol       Date:  2010-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.